{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:42:00Z","timestamp":1790404920774,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Insurance status has been associated with disparities in stage at cancer diagnosis. We examined how Medicaid expansion (ME) impacted diagnoses, surgical treatment, use of neoadjuvant therapies (NCRT), and outcomes for Stage II and III rectal cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY DESIGN:<\/jats:title>\n            <jats:p>We used 2010-2017 American College of Surgeons National Cancer Database (NCDB) to identify patients ages 18-65, with Medicaid as primary form of payment, and were diagnosed with Stage II or III rectal cancer. Patients were stratified based on Census bureau division\u2019s ME adoption rates of High, Medium, Low. Overall trends were examined, and patient characteristics and outcomes were compared before and after ME date of 1\/1\/2014.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Over 8 years of NCDB data examined, there was an increasing trend of Stage II and III rectal cancer diagnoses, surgical resection, and use of NCRT for Medicaid patients. We observed an increase in age, proportion of White Medicaid patients in Low ME divisions, and proportion of fourth income quartile patients in High ME divisions. Univariate analysis showed decreased use of open surgery for all 3 categories after ME, but adjusted odds ratios (aOR) were not significant based on multivariate analysis. NCRT utilization increased after ME for all 3 ME adoption categories and aOR significantly increased for Low and High ME divisions. ME significantly decreased 90-day mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Medicaid expansion had important impacts on increasing Stage II and III rectal cancer diagnoses, use of NCRT, and decreased 90-day mortality for patients with Medicaid. Our study supports increasing health insurance coverage to improve Medicaid patient outcomes in rectal cancer care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/xcs.0000000000000010","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T01:07:55Z","timestamp":1649120875000},"page":"54-63","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Impact of Medicaid Expansion on the Diagnosis, Treatment, and Outcomes of Stage II and III Rectal Cancer Patients"],"prefix":"10.1097","volume":"234","author":[{"given":"Mayin","family":"Lin","sequence":"first","affiliation":[{"name":"From the MercyOne Des Moines Surgical Group (Lin, Raman), Des Moines, IA"},{"name":"the Department of Surgery, Creighton University, Omaha, NE (Lin, Raman)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makayla","family":"O\u2019Guinn","sequence":"additional","affiliation":[{"name":"the General Surgery Residency Program, MercyOne Des Moines Medical Center (O\u2019Guinn, Zipprer), Des Moines, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Zipprer","sequence":"additional","affiliation":[{"name":"the General Surgery Residency Program, MercyOne Des Moines Medical Center (O\u2019Guinn, Zipprer), Des Moines, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Hsieh","sequence":"additional","affiliation":[{"name":"the Department of Animal Science, Iowa State University, Ames, IA (Hsieh)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo Torices","family":"Dardon","sequence":"additional","affiliation":[{"name":"the General Surgery Residency Program, NewYork-Presbyterian\/Queens, Flushing, NY (Dardon)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Raman","sequence":"additional","affiliation":[{"name":"From the MercyOne Des Moines Surgical Group (Lin, Raman), Des Moines, IA"},{"name":"the Department of Surgery, Creighton University, Omaha, NE (Lin, Raman)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Foglia","sequence":"additional","affiliation":[{"name":"the Department of Surgery, NewYork-Presbyterian\/Queens, Weill Cornell Medicine, Flushing, NY (Foglia, Chao)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Y","family":"Chao","sequence":"additional","affiliation":[{"name":"the Department of Surgery, NewYork-Presbyterian\/Queens, Weill Cornell Medicine, Flushing, NY (Foglia, Chao)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"R1-20250821","first-page":"7","article-title":"Cancer Statistics, 2021.","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R4-20250821","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-20250821","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer.","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"R6-20250821","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jamcollsurg.2018.01.057","article-title":"Evaluating the current status of rectal cancer care in the US: where we stand at the start of the Commission on Cancer\u2019s National Accreditation Program for rectal cancer.","volume":"226","author":"Brady","year":"2018","journal-title":"J Am Coll Surg"},{"key":"R7-20250821","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1002\/cncr.25317","article-title":"Insurance status and survival disparities among nonelderly rectal cancer patients in the National Cancer Data Base.","volume":"116","author":"Robbins","year":"2010","journal-title":"Cancer"},{"key":"R8-20250821","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1007\/s10620-008-0669-0","article-title":"Factors associated with colon cancer stage at diagnosis.","volume":"54","author":"Halpern","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R10-20250821","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamaoncol.2019.5672","article-title":"Association of insurance status and racial disparities with the detection of early-stage breast cancer.","volume":"6","author":"Ko","year":"2020","journal-title":"JAMA Oncol"},{"key":"R14-20250821","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.amepre.2019.02.015","article-title":"Changes in breast and colorectal cancer screening after Medicaid expansion under the Affordable Care Act.","volume":"57","author":"Fedewa","year":"2019","journal-title":"Am J Prev Med"},{"key":"R15-20250821","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jamainternmed.2016.4419","article-title":"Changes in utilization and health among low-income adults after medicaid expansion or expanded private insurance.","volume":"176","author":"Sommers","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R16-20250821","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jamcollsurg.2020.10.021","article-title":"Association between medicaid expansion and diagnosis and management of colon cancer.","volume":"232","author":"Hoehn","year":"2021","journal-title":"J Am Coll Surg"},{"key":"R17-20250821","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.amjsurg.2019.07.003","article-title":"The impact of the affordable care act (ACA) Medicaid Expansion on access to minimally invasive surgical care.","volume":"219","author":"Eguia","year":"2020","journal-title":"Am J Surg"},{"key":"R20-20250821","doi-asserted-by":"crossref","first-page":"S706","DOI":"10.2105\/AJPH.2015.302876","article-title":"Medicaid coverage expansion and implications for cancer disparities.","volume":"105 Suppl 5","author":"Choi","year":"2015","journal-title":"Am J Public Health"},{"key":"R21-20250821","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1072-7515(02)01765-9","article-title":"Impact of a cancer screening program on breast cancer stage at diagnosis in a medically underserved urban community.","volume":"196","author":"Oluwole","year":"2003","journal-title":"J Am Coll Surg"},{"issue":"Suppl 1","key":"R22-20250821","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1077558700057001S06","article-title":"Racial and ethnic differences in access to medical care.","volume":"57","author":"Mayberry","year":"2000","journal-title":"Med Care Res Rev"},{"key":"R26-20250821","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/DCR.0000000000000840","article-title":"The rationale for and reality of the new national accreditation program for rectal cancer.","volume":"60","author":"Wexner","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"R27-20250821","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-0040-1713749","article-title":"Improving rectal cancer outcomes with the national accreditation program for rectal cancer.","volume":"33","author":"Wexner","year":"2020","journal-title":"Clin Colon Rectal Surg"},{"key":"R28-20250821","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/DCR.0000000000000883","article-title":"Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American Society of Colon and Rectal Surgeons and Society of American Gastrointestinal and Endoscopic Surgeons.","volume":"60","author":"Carmichael","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"R29-20250821","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1470-2045(13)70016-0","article-title":"Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial.","volume":"14","author":"Pas","year":"2013","journal-title":"Lancet Oncol Elsevier"},{"key":"R30-20250821","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa1414882","article-title":"A randomized trial of laparoscopic versus open surgery for rectal cancer.","volume":"372","author":"Bonjer","year":"2015","journal-title":"N Engl J Med"},{"key":"R31-20250821","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1001\/jama.2015.10529","article-title":"Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 Randomized Clinical Trial.","volume":"314","author":"Fleshman","year":"2015","journal-title":"JAMA"},{"key":"R32-20250821","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jama.2015.12009","article-title":"Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in Rectal Cancer: the ALaCaRT Randomized Clinical Trial.","volume":"314","author":"Stevenson","year":"2015","journal-title":"JAMA"},{"key":"R33-20250821","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3748\/wjg.v17.i7.862","article-title":"Minimally invasive surgery for rectal cancer: are we there yet?","volume":"17","author":"Champagne","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R34-20250821","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jss.2017.09.046","article-title":"Trends in laparoscopic colorectal surgery over time from 2005-2014 using the NSQIP database.","volume":"223","author":"Davis","year":"2018","journal-title":"J Surg Res"},{"key":"R36-20250821","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1463-1318.2012.03044.x","article-title":"Changing trends in rectal cancer surgery in Ontario: 2002-2009.","volume":"14","author":"Musselman","year":"2012","journal-title":"Colorectal Dis"},{"key":"R37-20250821","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/SLA.0000000000001781","article-title":"Insurance status, not race, is associated with use of minimally invasive surgical approach for rectal cancer.","volume":"265","author":"Turner","year":"2017","journal-title":"Ann Surg"},{"key":"R38-20250821","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00464-010-1345-y","article-title":"Disparities in access to basic laparoscopic surgery at U.S. academic medical centers.","volume":"25","author":"Varela","year":"2011","journal-title":"Surg Endosc"},{"key":"R39-20250821","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jss.2020.07.056","article-title":"Racial disparities in outcomes after common abdominal surgical procedures-the impact of access to a minimally invasive approach.","volume":"257","author":"Haider","year":"2021","journal-title":"J Surg Res"},{"key":"R40-20250821","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J Clin Oncol"},{"key":"R41-20250821","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.","volume":"15","author":"Bosset","year":"2014","journal-title":"Lancet Oncol"},{"key":"R43-20250821","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/cncr.29993","article-title":"Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: an analysis from the National Cancer Data Base.","volume":"122","author":"Sineshaw","year":"2016","journal-title":"Cancer"},{"key":"R44-20250821","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/jnci\/91.16.1409","article-title":"Effects of health insurance and race on early detection of cancer.","volume":"91","author":"Roetzheim","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R45-20250821","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.MLR.0000065126.73750.D1","article-title":"Late stage cancers in a Medicaid-insured population.","volume":"41","author":"Bradley","year":"2003","journal-title":"Med Care"},{"key":"R46-20250821","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1470-2045(08)70032-9","article-title":"Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.","volume":"9","author":"Halpern","year":"2008","journal-title":"Lancet Oncol"},{"key":"R47-20250821","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2011.36.8399","article-title":"Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.","volume":"30","author":"Wu","year":"2012","journal-title":"J Clin Oncol"},{"key":"R48-20250821","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amepre.2011.03.010","article-title":"Effects of healthcare reforms on coverage, access, and disparities: quasi-experimental analysis of evidence from Massachusetts.","volume":"41","author":"Pande","year":"2011","journal-title":"Am J Prev Med"},{"key":"R49-20250821","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMsa1212321","article-title":"The Oregon experiment\u2013effects of Medicaid on clinical outcomes.","volume":"368","author":"Baicker","year":"2013","journal-title":"N Engl J Med"},{"key":"R50-20250821","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1246183","article-title":"Medicaid increases emergency-department use: evidence from Oregon\u2019s Health Insurance Experiment.","volume":"343","author":"Taubman","year":"2014","journal-title":"Science"},{"key":"R52-20250821","first-page":"250","article-title":"Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.","volume":"68","author":"Wolf","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R53-20250821","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/jama.2021.6238","article-title":"Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement.","volume":"325","author":"Davidson","year":"2021","journal-title":"J Am Med Assoc"}],"container-title":["Journal of the American College of Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/XCS.0000000000000010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:02:40Z","timestamp":1755806560000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/XCS.0000000000000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/xcs.0000000000000010","relation":{},"ISSN":["1072-7515"],"issn-type":[{"value":"1072-7515","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}